Truist Financial’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,996
| Closed | -$392K | – | 2576 |
|
|
2022
Q3 | $392K | Buy |
5,996
+2,699
| +82% | +$176K | ﹤0.01% | 1937 |
|
|
2022
Q2 | $200K | Sell |
3,297
-396
| -11% | -$24K | ﹤0.01% | 2434 |
|
|
2022
Q1 | $232K | Sell |
3,693
-423
| -10% | -$26.6K | ﹤0.01% | 2443 |
|
|
2021
Q4 | $312K | Sell |
4,116
-3,978
| -49% | -$302K | ﹤0.01% | 2299 |
|
|
2021
Q3 | $906K | Buy |
8,094
+1,416
| +21% | +$159K | ﹤0.01% | 1655 |
|
|
2021
Q2 | $1.08M | Sell |
6,678
-478
| -7% | -$77.4K | ﹤0.01% | 1595 |
|
|
2021
Q1 | $872K | Buy |
7,156
+345
| +5% | +$42K | ﹤0.01% | 1661 |
|
|
2020
Q4 | $1.04M | Buy |
6,811
+2,972
| +77% | +$455K | ﹤0.01% | 1445 |
|
|
2020
Q3 | $321K | Sell |
3,839
-634
| -14% | -$53K | ﹤0.01% | 1950 |
|
|
2020
Q2 | $329K | Sell |
4,473
-1,112
| -20% | -$81.8K | ﹤0.01% | 1870 |
|
|
2020
Q1 | $236K | Buy |
+5,585
| New | +$236K | ﹤0.01% | 1988 |
|